Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 117 | SFEBES2026

Society for Endocrinology BES 2026

Harrogate, United Kingdom
02 Mar 2026 - 04 Mar 2026

Card image cap
SfE BES is the UK's leading endocrinology meeting. It will return to Harrogate in 2026.

Poster Presentations

Neuroendocrinology and Pituitary

Previous section
Metabolism, Obesity and Diabetes
Table of contents
Next section
Nursing Practice

ea0117p163 | Neuroendocrinology and Pituitary

Sellar extraventricular neurocytoma: the great pituitary adenoma mimic

ea0117p164 | Neuroendocrinology and Pituitary

CNS relapse of diffuse large B-cell lymphoma presenting with panhypopituitarism and diabetes insipidus: a case report

ea0117p165 | Neuroendocrinology and Pituitary

Syndrome of inappropriate antidiuresis (SIAD) secondary to high-grade neuroendocrine prostate cancer (NEPC): a rare presentation

ea0117p166 | Neuroendocrinology and Pituitary

Acromegaly – a single centre retrospective analysis of outcomes post radiotherapy

ea0117p167 | Neuroendocrinology and Pituitary

Histological and biochemical analysis of pituitary surgeries performed over a decade

ea0117p168 | Neuroendocrinology and Pituitary

Diagnostic pitfalls in endogenous hyperinsulinemia hypoglycemia: a rare case of insulin autoimmune syndrome

ea0117p169 | Neuroendocrinology and Pituitary

Hypophysitis masquerading as pituitary macroadenoma: clinical diagnostic challenge

ea0117p170 | Neuroendocrinology and Pituitary

Evaluation of 1.8% Hypertonic Saline Use in Acute Severe Hyponatraemia: An Audit of Patients Admitted to a Medical High Dependency Unit

ea0117p171 | Neuroendocrinology and Pituitary

Osilodrostat therapy and 11C-methionine PET to IMprove corticotroph pituitary Adenoma detection and Localisation in patients with Cushing's disease (OPTIMAL); study design and rationale

ea0117p172 | Neuroendocrinology and Pituitary

Rivaroxaban Prophylaxis for VTE Prevention in ACTH-Dependent Cushing’s Syndrome: Safety and Effectiveness in a Single-Centre Retrospective Cohort

ea0117p173 | Neuroendocrinology and Pituitary

A rare case of isolated ACTH deficiency (IAD) following COVID

ea0117p174 | Neuroendocrinology and Pituitary

A rare case of triple endocrine dysfunction following immune checkpoint inhibitor therapy

ea0117p175 | Neuroendocrinology and Pituitary

Unmasking of Idiopathic Parkinson's Disease (PD) following cessation of Cabergoline in a patient with Macroprolactinoma

ea0117p176 | Neuroendocrinology and Pituitary

A rare case of ectopic ACTH production and carcinoid syndrome from a metastasized small bowel neuroendocrine tumour

ea0117p177 | Neuroendocrinology and Pituitary

A case of insulinoma in an elderly man: diagnostic and treatment challenges

ea0117p178 | Neuroendocrinology and Pituitary

Secondary hypogonadism in adulthood: late presentation of congenital obstructive hydrocephalus with pituitary stalk distortion

ea0117p179 | Neuroendocrinology and Pituitary

Development of hypopituitarism after fractionated pituitary radiotherapy for pituitary disease: a single-centre audit

ea0117p180 | Neuroendocrinology and Pituitary

Ectopic ACTH-producing pulmonary carcinoid tumor presenting with cushing syndrome

ea0117p181 | Neuroendocrinology and Pituitary

Breast cancer and Venous Thromboembolic disease (VTE) in patients with Multiple Endocrine Neoplasia type 1 (MEN 1) in The Sheffield NET Centre, European Neuroendocrine Centre of Excellence

ea0117p182 | Neuroendocrinology and Pituitary

Outcomes of hospitalized patients with severe hyponatremia: findings from the pilot of HypoNa-RESCUE, a multicentre observational study

ea0117p183 | Neuroendocrinology and Pituitary

Reversible central adrenal insufficiency in a patient with high dose loperamide use post bowel surgery

ea0117p184 | Neuroendocrinology and Pituitary

Hypertonic saline test: a salty journey from a ‘feared’ procedure to a safe, effective diagnostic for arginine vasopressin deficiency

ea0117p185 | Neuroendocrinology and Pituitary

Involvement of GM3 gangliosides in acromegaly associated insulin resistance

ea0117p186 | Neuroendocrinology and Pituitary

Spindle cell oncocytoma presenting with mass effect and panhypopituitarism. a case report

ea0117p187 | Neuroendocrinology and Pituitary

Haplotypes for disease-causing aip variants are geographically spread across the UK and ireland, but do not influence disease severity

ea0117p188 | Neuroendocrinology and Pituitary

The challenges of a rapidly progressive pituitary metastasis

ea0117p189 | Neuroendocrinology and Pituitary

Acromegaly management and outcomes: a 47-year single-centre experience

ea0117p190 | Neuroendocrinology and Pituitary

Inflammatory pituitary mass in a young female, treated as pituitary abscess caused by cutibacterium acnes

ea0117p191 | Neuroendocrinology and Pituitary

CAM2029 octreotide subcutaneous depot maintains control of IGF-I and symptoms of acromegaly across a 4-week dosing interval and for intervals greater than 28 days: data from the ACROINNOVA 1 trial

ea0117p192 | Neuroendocrinology and Pituitary

Lost to follow-up: the challenge of managing a treatment-resistant giant prolactinoma

ea0117p193 | Neuroendocrinology and Pituitary

Primary pituitary lymphoma in a patient with C1 esterase inhibitor deficiency and MGUS: a diagnostic challenge

ea0117p194 | Neuroendocrinology and Pituitary

Rare AIP exon 2–3 large deletion linking acromegaly and thyroid carcinoma: first case series from Albania

ea0117p195 | Neuroendocrinology and Pituitary

The role of Sox11 in hypothalamic-pituitary development and the pathogenesis of hypogonadotropic hypogonadism

ea0117p196 | Neuroendocrinology and Pituitary

Drug induced liver injury following low-dose tolvaptan for SIADH: a rare adverse event prompting a change in monitoring

ea0117p197 | Neuroendocrinology and Pituitary

Cushing-like but not Cushing Disease

ea0117p198 | Neuroendocrinology and Pituitary

When suppression stimulates: persistent testosterone elevation from gonadotrophin-releasing hormone agonist therapy in prostate cancer

ea0117p199 | Neuroendocrinology and Pituitary

Audit of testing for growth hormone deficiency (GHD) in teenage and young adults (TYA) and adults previously treated with cranial radiotherapy at a Tertiary Oncology Hospital

ea0117p200 | Neuroendocrinology and Pituitary

Case report: pharmacological and non-pharmacological therapies in the management of refractory hypoglycaemia secondary to malignant insulinoma

ea0117p201 | Neuroendocrinology and Pituitary

Parotid gland tumours in acromegaly: rare coincidence or IGF-related association?

ea0117p202 | Neuroendocrinology and Pituitary

Peptide receptor radionuclide therapy (PRRT) as a treatment option in metastatic ovarian neuroendocrine tumour with carcinoid syndrome and treated carcinoid heart disease: a case report

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2026 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more